Bacteriological Spectrum and Drug Resistance Among Patients Associated With Bloodstream Infection in Intensive Care Units in the Affiliated Hospital of Jiaxing University From 2021 to 2023

Bloodstream infections (BSI) in ICU settings are associated with high morbidity, mortality, and healthcare costs. The ICU environment, with its high use of invasive devices and immunocompromised patients, fosters an increased risk for multidrug resistance (MDR) pathogens, complicating treatment stra...

Full description

Saved in:
Bibliographic Details
Main Authors: Yucheng Xie, Xiaochun Tan, Wei Wang, Bailong Hou, Minjie Mao, Xiaoqin Niu, Qinlong Yu, Weifeng Shen
Format: Article
Language:English
Published: Wiley 2025-01-01
Series:Canadian Journal of Infectious Diseases and Medical Microbiology
Online Access:http://dx.doi.org/10.1155/cjid/7841940
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849744183627087872
author Yucheng Xie
Xiaochun Tan
Wei Wang
Bailong Hou
Minjie Mao
Xiaoqin Niu
Qinlong Yu
Weifeng Shen
author_facet Yucheng Xie
Xiaochun Tan
Wei Wang
Bailong Hou
Minjie Mao
Xiaoqin Niu
Qinlong Yu
Weifeng Shen
author_sort Yucheng Xie
collection DOAJ
description Bloodstream infections (BSI) in ICU settings are associated with high morbidity, mortality, and healthcare costs. The ICU environment, with its high use of invasive devices and immunocompromised patients, fosters an increased risk for multidrug resistance (MDR) pathogens, complicating treatment strategies. Understanding the epidemiology and resistance patterns in these settings is essential for improving patient outcomes and guiding appropriate antimicrobial stewardship practices. This study retrospectively analyzed data from 640 blood culture samples collected in the ICU of the Affiliated Hospital of Jiaxing University between January 2021 and December 2023. The blood samples were appropriately collected and cultured. Matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry was employed to identify the isolated strains. Antimicrobial sensitivity was assessed using the VITEK2 system, the Epsilometer test (E-test), and the Kirby–Bauer disk diffusion method. All statistical analyses were conducted using IBM SPSS Statistics 22.0. A total of 391 bacterial pathogens (61.1%) were isolated. The predominant pathogens causing BSI were Gram-negative bacteria. The most prevalent pathogens during the period were coagulase-negative Staphylococci (CoNS, 17.1%), followed by Klebsiella pneumoniae (K. pneumoniae, 13.6%), Enterococcus spp (13.6%), Escherichia coli (E. coli, 12.3%), Acinetobacter baumannii (A. baumannii, 8.4%), and Staphylococcus aureus (S. aureus, 5.1%). Among the antibiotics tested, tigecycline, linezolid, vancomycin, and quinupristin/dalfopristin were effective against Staphylococci and Enterococci, although some CoNS strains exhibited resistance to vancomycin. Tigecycline showed effectiveness against the main gram-negative bacteria. Furthermore, multiple hospitalizations, comorbidity with diabetes, and the use of a central venous catheter were identified as significant risk factors for multidrug-resistant organisms (MDROs) in BSI cases. Pathogens isolated from the bloodstream of ICU patients exhibited significant drug resistance. We recommend strategies to mitigate the incidence of MDROs in BSI, including limiting the duration of hospital stays, closely monitoring underlying patient conditions, improving discharge plans, and strengthening transitional care, and prevent infections associated with central venous catheters.
format Article
id doaj-art-1359ca2d59b64fffa07108a53ebd6658
institution DOAJ
issn 1918-1493
language English
publishDate 2025-01-01
publisher Wiley
record_format Article
series Canadian Journal of Infectious Diseases and Medical Microbiology
spelling doaj-art-1359ca2d59b64fffa07108a53ebd66582025-08-20T03:21:44ZengWileyCanadian Journal of Infectious Diseases and Medical Microbiology1918-14932025-01-01202510.1155/cjid/7841940Bacteriological Spectrum and Drug Resistance Among Patients Associated With Bloodstream Infection in Intensive Care Units in the Affiliated Hospital of Jiaxing University From 2021 to 2023Yucheng Xie0Xiaochun Tan1Wei Wang2Bailong Hou3Minjie Mao4Xiaoqin Niu5Qinlong Yu6Weifeng Shen7Department of Clinical LaboratoryDepartment of Clinical LaboratoryDepartment of Clinical LaboratoryDepartment of Clinical LaboratoryDepartment of Clinical LaboratoryDepartment of Clinical LaboratoryDepartment of Clinical LaboratoryDepartment of Clinical LaboratoryBloodstream infections (BSI) in ICU settings are associated with high morbidity, mortality, and healthcare costs. The ICU environment, with its high use of invasive devices and immunocompromised patients, fosters an increased risk for multidrug resistance (MDR) pathogens, complicating treatment strategies. Understanding the epidemiology and resistance patterns in these settings is essential for improving patient outcomes and guiding appropriate antimicrobial stewardship practices. This study retrospectively analyzed data from 640 blood culture samples collected in the ICU of the Affiliated Hospital of Jiaxing University between January 2021 and December 2023. The blood samples were appropriately collected and cultured. Matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry was employed to identify the isolated strains. Antimicrobial sensitivity was assessed using the VITEK2 system, the Epsilometer test (E-test), and the Kirby–Bauer disk diffusion method. All statistical analyses were conducted using IBM SPSS Statistics 22.0. A total of 391 bacterial pathogens (61.1%) were isolated. The predominant pathogens causing BSI were Gram-negative bacteria. The most prevalent pathogens during the period were coagulase-negative Staphylococci (CoNS, 17.1%), followed by Klebsiella pneumoniae (K. pneumoniae, 13.6%), Enterococcus spp (13.6%), Escherichia coli (E. coli, 12.3%), Acinetobacter baumannii (A. baumannii, 8.4%), and Staphylococcus aureus (S. aureus, 5.1%). Among the antibiotics tested, tigecycline, linezolid, vancomycin, and quinupristin/dalfopristin were effective against Staphylococci and Enterococci, although some CoNS strains exhibited resistance to vancomycin. Tigecycline showed effectiveness against the main gram-negative bacteria. Furthermore, multiple hospitalizations, comorbidity with diabetes, and the use of a central venous catheter were identified as significant risk factors for multidrug-resistant organisms (MDROs) in BSI cases. Pathogens isolated from the bloodstream of ICU patients exhibited significant drug resistance. We recommend strategies to mitigate the incidence of MDROs in BSI, including limiting the duration of hospital stays, closely monitoring underlying patient conditions, improving discharge plans, and strengthening transitional care, and prevent infections associated with central venous catheters.http://dx.doi.org/10.1155/cjid/7841940
spellingShingle Yucheng Xie
Xiaochun Tan
Wei Wang
Bailong Hou
Minjie Mao
Xiaoqin Niu
Qinlong Yu
Weifeng Shen
Bacteriological Spectrum and Drug Resistance Among Patients Associated With Bloodstream Infection in Intensive Care Units in the Affiliated Hospital of Jiaxing University From 2021 to 2023
Canadian Journal of Infectious Diseases and Medical Microbiology
title Bacteriological Spectrum and Drug Resistance Among Patients Associated With Bloodstream Infection in Intensive Care Units in the Affiliated Hospital of Jiaxing University From 2021 to 2023
title_full Bacteriological Spectrum and Drug Resistance Among Patients Associated With Bloodstream Infection in Intensive Care Units in the Affiliated Hospital of Jiaxing University From 2021 to 2023
title_fullStr Bacteriological Spectrum and Drug Resistance Among Patients Associated With Bloodstream Infection in Intensive Care Units in the Affiliated Hospital of Jiaxing University From 2021 to 2023
title_full_unstemmed Bacteriological Spectrum and Drug Resistance Among Patients Associated With Bloodstream Infection in Intensive Care Units in the Affiliated Hospital of Jiaxing University From 2021 to 2023
title_short Bacteriological Spectrum and Drug Resistance Among Patients Associated With Bloodstream Infection in Intensive Care Units in the Affiliated Hospital of Jiaxing University From 2021 to 2023
title_sort bacteriological spectrum and drug resistance among patients associated with bloodstream infection in intensive care units in the affiliated hospital of jiaxing university from 2021 to 2023
url http://dx.doi.org/10.1155/cjid/7841940
work_keys_str_mv AT yuchengxie bacteriologicalspectrumanddrugresistanceamongpatientsassociatedwithbloodstreaminfectioninintensivecareunitsintheaffiliatedhospitalofjiaxinguniversityfrom2021to2023
AT xiaochuntan bacteriologicalspectrumanddrugresistanceamongpatientsassociatedwithbloodstreaminfectioninintensivecareunitsintheaffiliatedhospitalofjiaxinguniversityfrom2021to2023
AT weiwang bacteriologicalspectrumanddrugresistanceamongpatientsassociatedwithbloodstreaminfectioninintensivecareunitsintheaffiliatedhospitalofjiaxinguniversityfrom2021to2023
AT bailonghou bacteriologicalspectrumanddrugresistanceamongpatientsassociatedwithbloodstreaminfectioninintensivecareunitsintheaffiliatedhospitalofjiaxinguniversityfrom2021to2023
AT minjiemao bacteriologicalspectrumanddrugresistanceamongpatientsassociatedwithbloodstreaminfectioninintensivecareunitsintheaffiliatedhospitalofjiaxinguniversityfrom2021to2023
AT xiaoqinniu bacteriologicalspectrumanddrugresistanceamongpatientsassociatedwithbloodstreaminfectioninintensivecareunitsintheaffiliatedhospitalofjiaxinguniversityfrom2021to2023
AT qinlongyu bacteriologicalspectrumanddrugresistanceamongpatientsassociatedwithbloodstreaminfectioninintensivecareunitsintheaffiliatedhospitalofjiaxinguniversityfrom2021to2023
AT weifengshen bacteriologicalspectrumanddrugresistanceamongpatientsassociatedwithbloodstreaminfectioninintensivecareunitsintheaffiliatedhospitalofjiaxinguniversityfrom2021to2023